Medinotec Inc. (MDNC) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
NORTHLANDS DECO PARK, 10 NEW MARKET ST. JOHANNESBURG, 2169 |
| State of Incorp. | NV |
| Fiscal Year End | February 28 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 11/30/2025 MRQ | 2/28/2025 | 11/30/2024 MRQ | 2/29/2024 | 2/28/2023 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 2,770 | 2,677 | 2,809 | 2,827 | |||
| Cash and cash equivalent | 2,770 | 2,677 | 2,809 | 2,827 | |||
| Receivables | 2,612 | 682 | 590 | 21 | |||
| Inventory, net of allowances, customer advances and progress billings | 988 | 1,151 | 863 | 354 | |||
| Inventory | 988 | 1,151 | 863 | 354 | |||
| Other current assets | 53 | 100 | 117 | 167 | |||
| Other undisclosed current assets | 311 | ||||||
| Total current assets: | 6,423 | 4,920 | 4,379 | 3,369 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 37 | 45 | 62 | ||||
| Property, plant and equipment | 348 | 378 | 320 | 407 | |||
| Other undisclosed noncurrent assets | 19 | 43 | 714 | ||||
| Total noncurrent assets: | 386 | 442 | 425 | 1,121 | |||
| TOTAL ASSETS: | 6,809 | 5,363 | 4,804 | 4,490 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 1,477 | 1,447 | 802 | 71 | |||
| Accounts payable | 1,256 | 1,071 | 609 | 54 | |||
| Accrued liabilities | 78 | 45 | 79 | 58 | |||
| Other undisclosed accounts payable and accrued liabilities | 143 | 331 | 114 | (40) | |||
| Other undisclosed current liabilities | 28 | 28 | 26 | ||||
| Total current liabilities: | 1,505 | 1,475 | 827 | 71 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 940 | 1,041 | 1,770 | ||||
| Long-term debt, excluding current maturities | 940 | 1,041 | 1,770 | ||||
| Liabilities, other than long-term debt | 13 | 21 | 40 | ||||
| Operating lease, liability | 13 | 21 | 40 | ||||
| Other undisclosed noncurrent liabilities | 80 | ||||||
| Total noncurrent liabilities: | 1,033 | 1,062 | 1,810 | ||||
| Other undisclosed liabilities | 1,863 | ||||||
| Total liabilities: | 2,538 | 2,537 | 2,637 | 1,934 | |||
| Equity | |||||||
| Equity, attributable to parent, including: | 4,271 | 2,826 | 2,167 | 2,556 | |||
| Common stock | 12 | 12 | 12 | 12 | |||
| Additional paid in capital | 3,296 | 3,296 | 3,296 | ||||
| Accumulated other comprehensive income | 45 | 77 | 100 | 85 | |||
| Other undisclosed equity, attributable to parent | 918 | (559) | (1,241) | 2,460 | |||
| Total equity: | 4,271 | 2,826 | 2,167 | 2,556 | |||
| TOTAL LIABILITIES AND EQUITY: | 6,809 | 5,363 | 4,804 | 4,490 | |||
Income Statement (P&L) ($ in thousands)
| 11/30/2025 TTM | 2/28/2025 | 11/30/2024 TTM | 2/29/2024 | 2/28/2023 | ||
|---|---|---|---|---|---|---|
| Revenues | 9,114 | 10,996 | 5,020 | 1,000 | ||
| Cost of revenue | (2,495) | |||||
| Other undisclosed gross profit | (4,253) | (3,677) | (2,578) | (418) | ||
| Gross profit: | 4,861 | 4,825 | 2,442 | 582 | ||
| Operating expenses | 1,669 | 975 | 1,842 | (1,047) | ||
| Other undisclosed operating loss | (3,339) | (3,771) | (3,684) | |||
| Operating income (loss): | 3,191 | 2,028 | 601 | (465) | ||
| Nonoperating income (expense) | (167) | (861) | (854) | 74 | ||
| Other nonoperating income (expense) | 0 | (10) | 4 | 51 | ||
| Interest and debt expense | 277 | (156) | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 3,024 | 1,167 | 23 | (548) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (277) | 156 | ||||
| Income (loss) from continuing operations before income taxes: | 3,024 | 1,167 | (254) | (391) | ||
| Income tax expense (benefit) | (329) | 39 | ||||
| Net income (loss): | 3,024 | 838 | (254) | (353) | ||
| Other undisclosed net loss attributable to parent | (865) | (271) | (151) | |||
| Net income (loss) available to common stockholders, diluted: | 2,159 | 567 | (405) | (353) | ||
Comprehensive Income ($ in thousands)
| 11/30/2025 TTM | 2/28/2025 | 11/30/2024 TTM | 2/29/2024 | 2/28/2023 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | 3,024 | 838 | (254) | (353) | ||
| Other comprehensive income | 61 | 16 | ||||
| Other undisclosed comprehensive income (loss) | (91) | 81 | ||||
| Comprehensive income (loss): | 3,024 | 808 | (238) | (272) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (920) | (295) | (151) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | 2,104 | 513 | (389) | (272) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.